Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.
Also called NCT04952051
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Registry
-
NCT04952051
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04952051. Randomized; no masking; primary purpose treatment. Start 2014-07-01 (actual); primary completion 2019-07-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Enalapril Folic Acid Tablets Combined With amlodipine
- Intervention (Drug)
- Enalapril Folic Acid Tablets Combined With hydrochlorothiazide
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- National Clinical Research Center, Southern Medical University
- Collaborator
- Ningbo Yinzhou Community Health Service Center
Record details
- Record id
cardio:ct-nct04952051- Content hash
7f94a7de706d9dfe0f376e931c768f42ae4a7f12a521f7e88d1673026ebd3b0a